Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

China flag China · Delayed Price · Currency is CNY
6.73
+0.11 (1.66%)
Mar 10, 2026, 10:55 AM CST
10.51%
Market Cap 4.15B
Revenue (ttm) 691.16M
Net Income (ttm) -520.64M
Shares Out 627.62M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,409,520
Average Volume 41,949,571
Open 6.43
Previous Close 6.62
Day's Range 6.43 - 6.78
52-Week Range 4.60 - 10.07
Beta 0.67
RSI 47.97
Earnings Date Apr 29, 2026

About SHE:300639

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/i... [Read more]

Sector Healthcare
Founded 2003
Employees 2,205
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300639
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.